Sort
82,697 grants matching “vaccine development”
Development Structure and Function of Broadly Neutralizing anti-HIV Antibodies
$4,894,251Pamela J Bjorkman · California Institute Of Technology · P01 · FY2016 · AI
Harvard University Center for AIDS Research
$4,894,199Rajesh T Gandhi · Harvard University · P30 · FY2019 · AI
Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases
$4,889,710David Bruyette · Anivive Lifesciences, Inc · N01 · FY2024 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials Unit
$4,889,495Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2025 · AI
Eliciting VRC01-like bNAbs by Specifically Designed Env Immunogens
$4,886,015Leonidas A Stamatatos · Fred Hutchinson Cancer Research Center · U19 · FY2020 · AI
GM-CSF-Adjuvanted Clade C DNA/MVA and MVA/MVA Vaccines
$4,885,098Harriet L Robinson · Geovax, Inc. · U19 · FY2010 · AI
UAB Center for AIDS Research
$4,882,714Michael S. Saag · University Of Alabama At Birmingham · P30 · FY2012 · AI
External Quality Assurance Program Oversight Laboratory (EQAPOL)
$4,868,722Thomas Denny · Duke University · N01 · FY2022 · AI
DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity
$4,862,342Paul Glyndwr Thomas · St. Jude Children'S Research Hospital · U01 · FY2023 · AI
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$4,860,891Jacques F Banchereau · Baylor Research Institute · U19 · FY2009 · AI
Strategically Engineered Multi-Antigen KSHV Vaccine: Integrating Humoral and Cellular Immunity for Effective Protection
$4,857,475Ting-Ting Wu · University Of California Los Angeles · U01 · FY2025 · CA
B-cell Biology of Mucosal Immune Protection from SIV Challenge
$4,854,281Eric Hunter · Emory University · U19 · FY2015 · AI
Enhancing anti-tumor immunity in head and neck neoplasms
$4,850,901Clint Allen · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Cancer Immunotherapy
$4,841,882James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Development of Alphavirus Replicon Vaccine Against SARS
$4,839,367Alphavax Human Vaccines, Inc. · UC1 · FY2004 · AI
Center for Translational Research in Health Disparities
$4,833,611Kevin Sean Kimbro · Morehouse School Of Medicine · U54 · FY2025 · MD
Adaptive and Innate Immunity, Memory and Repertoire in Vaccination and Infection
$4,833,207Mark M Davis · Stanford University · U19 · FY2016 · AI
Advanced Development of a Multivalent Vaccine Candidate for Filovirus and Lassa Fever
$4,833,059Matthias Schnell · Thomas Jefferson University · N01 · FY2018 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$4,832,360Peter Leon Collins · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
ATN Coordinating Center
$4,827,126Craig M Wilson · University Of Alabama At Birmingham · U01 · FY2010 · HD
Multiscale analysis of influenza host-pathogen interactions: Fluomics
$4,822,003Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2013 · AI
Task B08: Development and Use of a Non-Human Primate Model of SARS-CoV-2 Infection
$4,821,458Karen Thompson · Battelle Centers/Pub Hlth Res & Evaluatn · N01 · FY2020 · AI
Center for Human Immunology
$4,820,939Yasmine Belkaid · National Institute Of Allergy And Infectious Diseases · ZIC · FY2019 · AI
Conjugate nanoparticle platform development for HIV-1 envelope immunogens
$4,818,748Kevin O Saunders · Duke University · U19 · FY2023 · AI
Infectious Diseases Research Technologies Core - RML
$4,812,299Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2012 · AI